Medicinal mushrooms: Towards a new horizon

Pharmacognosy Reviews

Volumn 4, Issue 8, 2010, Pages 127-135

  Ganeshpurkar, A ^a   Rai, G ^a   Jain, A ^a  

^a Shri Ram Institute of Technology   (India)

Author keywords

Anticancer; antimicrobials; antioxidants; immunomodulators; mushrooms; myochemicals

Indexed keywords

5,8 EPIDIOXY 5A,8A ERGOSTA 6,22 DIEN 3B OL; 5AERGOSTA 7,22 DIEN 3B OL; AGARICUS BISPORUS EXTRACT; ANTIBIOTIC AGENT; ANTIDIABETIC AGENT; ANTIFUNGAL AGENT; ANTIHYPERTENSIVE AGENT; ANTINEOPLASTIC AGENT; ANTIPROTOZOAL AGENT; ANTIRHEUMATIC AGENT; ANTIVIRUS AGENT; APPLANOXIDIC ACID; BETA GLUCAN; GANODERMA LUCIDUM EXTRACT; GRIFOLA FRONDOSA EXTRACT; GRIFOLIC ACID; GRIFOLIN; HYPOCHOLESTEROLEMIC AGENT; IMMUNOMODULATING AGENT; KRESTIN; LENTINAN; LENTINULA EDODES EXTRACT; PHELLINUS RIMOSUS EXTRACT; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; PLEUROTUS FLORIDA EXTRACT; POLYSACCHARIDE; SCHIZOPHYLLAN; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AGARICUS BISPORUS; AGARICUS BRASILIENSIS; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROTOZOAL ACTIVITY; ANTIVIRAL ACTIVITY; CALVATIA CAELATA; CORIOLUS VERSICOLOR; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG STRUCTURE; EHRLICH ASCITES TUMOR; FUNCTIONAL FOOD; GANODERMA ANNULARE; GANODERMA LUCIDUM; GRIFOLA FRONDOSA; HERICIUM ERINACEUS; HOHENBUEHELIA SEROTINA; HUMAN; HYGROCYBE; HYGROPHORUS; HYPSIZIGUS MARMOREUS; IMMUNOMODULATION; IMMUNOPOTENTIATION; INONOTUS OBLIQUUS; LACTARIUS VELLEREUS; LENTINULA EDODES; LIVER METASTASIS; MEDICINAL PLANT; METASTASIS INHIBITION; MUSHROOM; NONHUMAN; PHELLINUS RIMOSUS; PIPTOPORUS BETULINUS; PLEUROTUS FLORIDA; PLEUROTUS OSTREATUS; REVIEW; SOLID TUMOR; SPARASSIS CRISPA; T LYMPHOCYTE ACTIVATION; TRAMETES VERSICOLOR;

ASCOMYCOTA; BASIDIOMYCOTA;

EID: 79957580982     PISSN: 09737847     EISSN: 09762787     Source Type: Journal    
DOI: 10.4103/0973-7847.70904     Document Type: Review

References (117)

1. Sadler M, Saltmarsh M. Functional Foods: The Consumer, the Products and the Evidence. Cambridge: Royal Society of Chemistry; 1998.
2. Hasler CM. Functional food: The western prospective. Nutr Rev. 1996;54:506-10.
3. Barasi M. Human Nutrition: A Health Perspective. London: Arnold;2003
4. Carter J. Food:Your Miracle Medicine.New York: Harper Collins Publishers Inc.1999.
5. Barbisan L.F., Spinardi-Barbisan ALS, Moreira ELT, Salvadori DMF, Ribeiro LR Eira AF. Agaricus blazei (Himematsutake) does not alter the development of rat diethylnitrosamine-initiated hepatic preneoplastic foci. Cancer Sci.2003;94:188-92.
6. Bellini MF, Giacomini NL, Eira AF, Ribeiro LR, Mantovani MS. Anticlastogenic effect of aqueous extracts of Agaricus blazei on CHO k1 cells, studying different developmental phases of the mushroom. Toxicol In Vitro. 2003;17:465-9. (Pubitemid 36776788)
7. Wasser SP, Weis AL. Medicinal properties of substances occurring in higher basidiomycete mushrooms: A modern prospective. Crit Rev Immunol 1999;19:65-96.
8. Wasser SP, Weis AL. Medicinal values of the genus Pleurotus (Fr) P.Krast (Agaricales S. R. Basidiomycetes). Int J Med Mushrooms.1999;1:69-70.
9. Chang ST, Miles PG. Mushrooms biology-a new discipline. Mycologist. 1992;6:64-5.
10. Hawksworth DL. Mushrooms: The extent of the unexplored potential. Int J Med Mushrooms 2001;3:333-7
11. nd ed. Seattle:Eastland Press; 1993.
12. Hobbs C. Medicinal Mushrooms: An Exploitation of Tradition, Healing and Culture.Santa Cruz: Botanica Press; 1995.
13. Breene W. Nutritional and medicinal value of speciality mushrooms. J Food Prod Mark.1990;53:883-94.
14. Jong SC., Birmingham JM. Medicinal benefits of the mushroom Ganoderma. Adv App Microbio. 1992;37:101-34.
15. Badger AM. Developments in Industrial Microbiology, In: Sarasota FL, Nash CH, Underkofler LA, editors. Proceedings of the Fortieth General Meeting of the Society for Industrial Microbiology Vol 25.Arlington VA,1983.p.274.
16. Hemnani T, Parihar MS. Reactive oxygen species and oxidative DNA damage. Indian J Physiol Pharmacol. 1998;42:440-52. (Pubitemid 28557746)
17. Bijalani RL, Physiology of aging, In:Bijlani RL, editor. Understanding Medical Physiology, New Delhi: Jaypee Brothers Medical Publications Private Ltd; 1995.p.38-42.
18. Halliwell B, Cross CE. Oxygen derived species: Their relation to human disease and environmental stress. Environ Health Perspect 1994;102:5-12.
19. Sharma JR. Ecology and distribution of Hymenochaetaceae. In: Sharma JR. editor., Hymenochaetaceae of India,Calcutta, India, Botanical Survey of India; 1995.p. 9-10.
20. Ying JZ, Mao XL, Ma QM, Zong YC, Wen HA. Icons of medicinal fungi from China. Xu YH, Translator. In: Ying JZ. editor. Illustrations of Chinese medicinal fungi. Beijing, Science Press; 1987. p.579-85.
21. Ajith TA, Janardhanan KK. Antioxidant and antiinfammatory activities of methanol extract of Phellinus rimosus. Indian J Exp Biol.2001;39:1166-9.
22. Ajith TA, Janardhanan KK. Antioxidant and antihepatotoxic activities of Phellinus rimosus (Berk) Pilat. J Ethnopharmacol.2002;81:387-91.
23. Ajith TA, Janardhanan KK. Chemopreventive activity of a macrofungus Phellinus rimosus against N=nitrosodiethylamine induced hepatocellular carcinoma in rat. J Exp Ther Oncol. 2006;5:309-21.
24. Zhao JD, Zhang XQ. Resources and taxonomy of Ling Zhi (ganoderma) in China. Proceedings of International Symposium Gganoderma Research, (October 24-26,). Beijing Medical University Beijing, China; 1994.
25. Liu GT. Recent advances in research of pharmacology and Clinical application of Ganoderma (P. Karst) species (Aphyllophoromycetideae) in China. Int J Med Mushrooms.1999;1:63-7
26. Mau JL, Lin HC, Chen CC. Antioxidant properties of several medicinal mushrooms. J Agric Food Chem. 2002;50:6072-7.
27. Loganathan KJ, Venkatakrishnan V, Shenbhagaraman R, Kaviyarasan V. Comparitive study on the antioxidant, anticancer and antimicrobial property of Agaricus bisporus (J. E.Lange) Imbach before and after boiling. Afr J Biotechnol.2009;8:654-61.
28. st century: Non green evolution. Int J Med Mushrooms. 1999;1:1-7.
29. Jose N, Janardhanan KK. Antioxidant and antitumor activity of Pleurotus florida. Curr Sci. 2000;79:941-3.
30. Jose N, Ajith TA, Janardhanan KK. Antioxidant, anti-inflammatory and antitumor activities of culinary medicinal mushroom Pleurotus pulmonarius (Fr.) Quel. (Agaricomycetideae). Int J Med Mushrooms. 2002;4:329-35.
31. Jones S, Janardhanan KK. Antioxidant and antitumor activity of Ganoderma lucidum (Curt.: Fr.) P. Karst.-Reishi (Aphyllophoromycetideae) from South India. Int J Med Mushrooms.2000;2:195-200.
32. Lakshmi B. Tilak JC, Adhikari S, Devasagayam TP, Janardhanan KK. Evaluation of antioxidant activity of selected Indian mushrooms. Pharm Biol. 2004;42:179-85. (Pubitemid 39611761)
33. Barros L, Ferreira IC, Baptista P. Phenolics and antioxidant activity of mushroom leucopaxillus giganteus mycelium at different carbon sources. Food Sci Technol Int.2008;14:47-55.
34. Karaman I, Sahin F, Güllüce M, Ogütçü H, Sengül M, Adigüzel A. Antimicrobial activity of aqueous and methanol extracts of Juniperus oxycedrus L. J Ethnopharmacol. 2003;85:213-35.
35. Hirasawa M, Shouji N, Neta T, Fukushima K, Takada K. Three kinds of antibacterial substances from Lentinus edodes (Berk.) Sing. (Shiitake, an edible mushroom). Int J Antimicrob Agents.1999;11:151-7.
36. Dulger B, Ergul CC, Gucin F. Antimicrobial activity of the macrofungus Lepista nuda. Fitoterapia.2002;73:695-7.
37. Lindequist U, Teuscher E, Narbe G. Neue Wirkstoffe aus Basidiomyceten. Z Phytother. 1990;11:139-49. (Pubitemid 20320064)
38. Smania EF, Delle MF, Smania A Jr, Yunes RA, Cuneo RS. Antifungal activity of sterols and triterpenes isolated from Ganoderma annulare. Fitoterapia 2003;74:375-7. (Pubitemid 36623301)
39. Smania A Jr, Delle MF, Smania EF, Cuneo RS. Antibacterial activity of steroidal compounds isolated from Ganoderma applanatum (Pers.) Pat. (Aphyllophoromycetideae) fruit body. Int J Med Mushrooms.1999;1:325-30.
40. Bender S, Dumitrache CN, Backhaus J, Christie G, Cross RF, Lonergan GT. A case for caution in assessing the antibiotic activity of extracts of culinary-medicinal Shiitake mushroom [Lentinus edodes (Berk.)Singer] (Agaricomycetidae). Int J Med Mushrooms.2003;5:31-5.
41. Ngai PH, Ng TB. Lentin, a novel and potent antifungal protein from shitake mushroom with inhibitory effects on activity of human immunodeficiency virus-1 reverse transcriptase and proliferation of leukemic cells. Life Sci.2003;73:3363-74. (Pubitemid 37311377)
42. Wang HX, Ng TB. Examination of lectins, polysaccharopeptide, polysaccharide, alkaloid, coumarin and trypsin inhibitors for inhibitory activity against human immunodeficiency virus reverse transcriptase and glycohydrolases. Planta Med.2001;67:669-72. (Pubitemid 32929581)
43. Wang HX, Ng TB. Isolation of a novel ubiquitin-like protein from Pleurotus ostreatus mushroom with anti-human immunodeficiency virus, translation-inhibitory, and ribonuclease activities. Biochem Biophys Res Commun. 2000;276:587-93.
44. Wang HX, Ng TB. Isolation of a ribonuclease from fruiting bodies of the wild mushroom Termitomyces globulus. Peptides 2003;24:973-7. (Pubitemid 37130169)
45. Lee YS, Kang YH, Jung JY, Lee S, Ohuchi K, Shin KH, et al. Protein glycation inhibitors from the fruiting body of Phellinus linteus. Biol Pharm Bull. 2008;31:1968-72.
46. Lu TL, Huang GJ, Lu TJ, Wu JB, Wu CH, Yang TC,et al. Hispolon from Phellinus linteus has antiproliferative effects via MDM2-recruited ERK1/2 activity in breast and bladder cancer cells. Food Chem Toxicol. 2009;47:2013-21.
47. Kim GY, Kim SH, Hwang SY, Kim HY, Park YM, Park SK, et al. Oral administration of proteoglycan isolated from Phellinus linteus in the prevention and treatment of collagen-induced arthritis in mice. Biol Pharm Bull. 2003;26:823-31.
48. Wang H, Ng TB. Ganodermin, an antifungal protein from fruiting bodies of the medicinal mushroom Ganoderma lucidum. Peptides.2006;27:27-30. (Pubitemid 43061031)
49. Komoda Y, Shimizu M, Sonoda Y, Sato Y. Ganoderic acid and its derivatives as cholesterol synthesis inhibitors. Chem Pharm Bull (Tokyo). 1989;37:531-3. (Pubitemid 19082605)
50. Su CY, Shiao MS, Wang CT. Predominant inhibition of ganodermic acid S on the thromboxane A2-dependent pathway in human platelets response to collagen. Biochim Biophys Acta. 1999;1437:223-34 .
51. Schlegel B, Luhmann U, Härtl A, Gräfe U. Piptamine, a new antibiotic produced by Piptoporus betulinus Lu 9-1. J Antibiot (Tokyo).2000;53:973-4.
52. Peuzuto JM. Plant derived anticancer agents. Biochem Pharmacol. 1997;53:121-33.
53. Wasser SP. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol.2002;60:258-74.
54. Dai YC, Xu MQ. Studies on the medicinal polypore, Phellinus baumii, and its kin, P. linteus. Mycotaxon 1998;67:191-200.
55. Song KS, Cho SM, Lee JH, Kim HM, Han SB, Ko KS, et al. B-lymphocyte-stimulating polysaccharide from mushroom Phellinus linteus. Chem Pharm Bull (Tokyo).1995;43:2105-8.
56. Kim GY, Park HS, Nam BH, Lee SJ, Lee JD. Purification and characterization of acidic proteo-heteroglycan from the fruiting body of Phellinus linteus (Berk. and M.A. Curtis) Teng. Bioresour Technol. 2003;89:81-7.
57. Lee HJ, Lim ES, Ahn KS, Shim BS, Kim HM, Gong SJ, et al. Cambodian Phellinus linteus inhibits experimental metastasis of melanoma cells in mice via regulation of urokinase type plasminogen activator. Biol Pharm Bull.2005;28:27-31.
58. Mizuno T. The extraction and development of antitumour-active polysaccharides from medicinal mushrooms in Japan. Int J Med Mushrooms. 1999;1:9-29.
59. Chen S. Anti-aromatase activity of phytochemicals in white button mushrooms (Agaricus bisporus). Cancer Res. 2006;66:12026-34.
60. Wu D, Pae M, Ren Z, Guo Z, Smith D, Meydani SN. Dietary supplementation with white button mushroom enhances natural killer cell activity in C57BL/6 mice. J Nutr.2007;137:1472-7. (Pubitemid 46855488)
61. th ed. Philadelphia: Lippincott Williams and Wilkins,1993.p. 273-4.
62. Gunde Cimmerman N, Freidrich J, Cimmerman A, Benicki N. Screening fungi for the production of an inhibitor of HMG CoA reductase, production of mevinolin by the fungi of the genus Pleurotus. FEMS Microbiol Lett. 1993;111:203-6. (Pubitemid 23242325)
63. Gunde-Cimmerman N. Medicinal value of the genus Pleurotus (Fr.) P. Kaest. (Agaricales s.l., Basidiomycetes). Int J Med Mushrooms.1999;1:69-80.
64. Chihara G, Chihara G, Hamuro J, Maeda YY, Arai Y,Fukuoka F. Fractionation and purification of the polysaccharides with marked antitumour activity especially leninan from Lentinun edodes. Cancer Res. 1970;30:2776-81.
65. Wasser SP, Weis AL. Medicinal properties of substances occurring in higher basidiomycete mushrooms: Current perspectives. Int J Med Mushrooms. 1999;1:31-62.
66. Taguchi T, Furue H, Kimura T, Kondo T, Hattori T, Ito I, et al. End-point results of Phase III study of Lentinan. Gan To Kagaku Ryoho. 1985;12:366-80.
67. Taguchi T, Furue H, Kimura T, Kondo T, Hattori T, Itoh T, et al.End point result of a randomized controlled study of the treatment of gastrointestinal cancer with a combination of lentinan and chemotherapeutic agents. Excerpta Medica.1985;151-65.
68. Kurashiga S, Akuzawa Y, Eudo F. Effects of Lentinus edodes, Grifola frondosa and Pleurotus ostreatus administration on cancer outbreaks and activities of macrophages and lymphocytes in mice treated with a carcinogen. Immunopharmacol Immunotoxicol. 1997;19:175-85.
69. Nishida I, Nanba H, Kuroda H. Antitumour activity exhibited by orally administered extracts from fruit-body of Grifola frondosa (Maitake). Chem Pharm Bull (Tokyo). 1988;36:1819-27.
70. Gu YH, Gowsala S. Cytotoxic effect of oyster mushroom Pleurotus ostreatus on human androgen-independent prostate cancer PC-3 Cells. J Med Food. 2006;9:196-204.
71. Wang HX, Gao J, Ng TB. A new lectin with highly potent antihepatoma and antisarcoma activities from the oyster mushroom Pleurotus ostreatus. Biochem Biophys Res Commun 2000;275:810-6.
72. Grube BJ, Eng ET, Kao YC, Kwon A , Chen S. White button mushroom phytochemicals inhibit aromatase activity and breast cancer cell proliferation. J Nutr. 2001;131:3288-93. (Pubitemid 33136151)
73. Ajith TA, Janardhanan KK. Cytotoxic and antitumor activities of a polypore macrofungus, Phellinus rimosus (Berk) Pilat. J Ethnopharmacol.2003;84: 157-62.
74. Kawagishi H, Ryuichi RI, Kanao T, Keishiro TM, Hitoshi S,Hagiwara IT, et al. Fractionation and antitumor activity of the water-insoluble residue of Agaricus blazei fruiting bodies. Carbohydr Res. 1989;186:267-73.
75. Lam YW, Ng TB, Wang HX. Antiproliferative and antimitogenic activities in a peptide from puffball mushroom Calvatia caelata. Biochem Biophys Res Commun. 2001;289:744-9. (Pubitemid 33152296)
76. Ma Y, Mizuno T, Ito H. Antitumor activity of some polysaccharides isolated from a Chinese mushroom, Huangmo, the fruiting body of Hohenbuehelia serotina. Agric Biol Chem. 1991;55:2701-10 .
77. Mizuno T, Zhuang C, Abe K, Okamoto H, Kiho T, Ukai S, et al. Antitumor and hypoglycemic activities of polysaccharides from the sclerotia and mycelia of Inonotus obliquus (Pers.: Fr.) Pil. (Aphyllophoromycetideae). Int J Med Mushrooms. 1999;1:301-16.
78. Tzianabos A. Polysaccharide immunomodulators as therapeutic agents: Structural aspects and biologic function. Clin Microbiol Rev. 2000;13:523-33.
79. Chihara G. Immunopharmacology of Lentinan, a polysaccharide isolated from Lentinus edodes: Its applications as a host defence potentiator. Int J Orient Med. 1992;17:57-77.
80. Ooi VE, Liu F. Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr Med Chem. 2000;7:715-29. (Pubitemid 30366638)
81. Hobbs C. Medicinal value of Lentinus edodes (Berk.) Sing. (Agaricomycetideae). A literature review. Int J Med Mushrooms. 2000;2:287-302.
82. Akoi T. Lentinan. Immunology Studies: Immune modulation agents and their mechanisms. In: Femchel RL, Chirgis MA.editors.Vol.25. Marcel Dekker, Inc., New York .1984 .p. 62-77.
83. Suga T, Maeda YY, Uchida H, Rokutanda M, Chihara G. Macrophage-mediated acute-phase transport protein production induced by Lentinan. Int J Immunopharmacol. 1986;8:691.
84. Maeda YY, Sakaizumi M, Moriwaki K, Yonekawa H. Genetic control of the expression of two biological activities of an antitumor polysaccharide, Lentinan. Int J Immunopharmacol.1991;13:977.
85. Chihara G. Immunopharmacology of Lentinan, a polysaccharide isolated from Lentinus edodes: Its applications as a host defence potentiator. Int J Orient Med.1992;17:57-77.
86. Bohn JA, BeMiller JN.(1-3)-β-D-Glucans as biological response modifiers: A review of structure-functional activity relationships. Carbohydr Polym.1995;28:3-14.
87. Yan R. Treatment of chronic hepatitis B with Wulingdan pill. J Fourth Milit Med Coll. 1987;8:380-3.
88. Shiao MS, Lee KR, Lin LJ, Wang CT. Natural products and biological activities of the Chinese medical fungus, Ganoderma lucidum. In: Ho CT, Osawa T, Huang MT, Rosen RT,editors. Food phyotchemicals for cancer prevention. II: Teas, spices and herbs. Washington DC:American Chemical Society;1994.p. 342-54.
89. Jong SC, Birmingham JM. Medicinal benefits of the mushroom Ganoderma. Adv Appl Microbiol. 1992;37:101-34.
90. Oh JY, Cho KJ, Chung SH. Activation of macrophages by GLB, a protein-polysaccharide of the growing tips of Ganoderma lucidum. Yakhakhoe Chi.1998;42:302-6.
91. Kino K, Sone T, Watanabe J. Immunomodulator, LZ-8, prevents antibody production in mice. Int J Immunopharmacol. 1991;13:1109-15.
92. Lee JW, Chung CH, Jeong H, Lee KH.Effects of alkali extract of Ganoderma lucidum IY007 on complement andres. Korean J Mycol. 1990;18:137-44.
93. Battle J, Ha TZ, Li CF. Ligand binding to the (1-3)-beta-D-glucan receptor stimulates NF-kappa B activation, but not apoptosis in U937 cells. Biochem Biophys Res Comm.1998;249:499-504.
94. Mueller A, Raptis J, Rice PJ, Kalbfleisch JH, Stout RD, Ensley HE, et al. The influence of glucan polymer structure and solution conformation on binding to (1-3)-beta-D-glucan receptors in human monocyte-like cell line. Glycobiology. 2000;10:339-46.
95. Kim HW, Kim BK. Biomedicinal triterperoids of Ganoderma lucidum (Curt.:Fr.) P. Karst. (Aphyllophoromycetideae). Int J Med Mushrooms.1999;1:121- 38.
96. Tzianabos A. Polysaccharide immunomodulators as therapeutic agents: Structural aspects and biologic function. Clin Microbiol Rev.2000;13:523-33.
97. Okazaki M, Adachi Y, Ohno N, Yadomae T. Structure-activity relationship of (1-3)-β-Dglucan in the induction of cytokine production from macrophages in vitro. Biol Pharm Bull.1995;18:1320-7.
98. Chye FY, Wong JY, Lee JS.Nutritional quality and antioxidant activity of selected edible wild mushrooms.Food Sci Technol Int.2008;14:375-84.
99. Khatun K, Mahtab H, Khanam PA, Sayeed MA, Khan KA. Oyster mushroom reduced blood glucose and cholesterol in diabetic subjects. Mymensingh Med J. 2007;16:94-9.
100. Bobek P, Galbavý S. Hypocholesterolemic and antiatherogenic effect of oyster mushroom (Pleurotus ostreatus) in rabbits. Nahrung. 1999;43:339-42. (Pubitemid 129569283)
101. de Lima Alves PL, Delmanto RD, Sugui MM, da Eira AF, Salvadori DM, Speit G. Letinula edodes (Berk.) Pegler (Shiitake) modulates genotoxic and mutagenic effects induced by alkylating agents in vivo. Mutat Res 2001;496:23-32.
102. Sugui MM, de Lima Alves PL, Delmanto RD, da Eira AF, Salvadori DM, Ribeiro LR. Antimutagenic effect of Lentinula edodes (BERK.) Pegler mushroom and possible variation among lineages. Food Chem Toxicol. 2003;41:555-60.
103. Miguel J, Garcia B, Espinosa ME, Ogura T. Volatile Compounds secreted by the oyster mushroom (Pleurotus ostreatus) and their antibacterial activities. J Agric Food Chem. 1997;45:4049-52. (Pubitemid 127485718)
104. Konno S, Aynehchi S, Dolin DJ, Schwartz AM, Choudhury MS, Tazakin HN. Anticancer and hypoglycemic effects of polysaccharides in edible and medicinal Maitake mushroom [Grifola frondosa (Dicks.:Fr.) S.F.Gray]. Int J Med Mushrooms. 2002;4:185-95.
105. Ohno N, Harada T, Masuzawa S, Miura NN, Adachi Y, Nakajima M, et al. Antitumor activity and hematopoietic response of a β - glucan extracted from an edible and medicinal mushroom Sparassis crispa Wulf.:Fr. (Aphylloromycetidae Int J Med Mushrooms. 2002;4:1326
106. Ohno N, Nameda S, Harada T, Miura NN, Adachi Y,Nakajima M, et al. Immunomodulating activity of a β-glucan preparation, SCG, extracted from a culinary-medicinal mushroom, Sparassis crispa Wulf.:Fr. (Aphyllophoromycetidae), and application to cancer patients. Int J Med Mushrooms.2003;5:359-68.
107. Lam SK, Ng TB. Hypsin, A novel thermostable ribosome inactivating protein with antifungal and antiproliferative activities from fruiting bodies of the edible mushroom Hypsizigus marmoreus. Biochem Biophys Res Commun.2001;285:1071- 5. (Pubitemid 32918047)
108. Mlinarič A, Kac J, Fatur T, Filipič M. Anti-genotoxic activity of the mushroom Lactarius vellereus extract in bacteria and in mammalian cells in vitro. Pharmazie.2004;59:217-21. (Pubitemid 38391428)
109. Tasaka K, Mio M, Izushi K, Akagi M, Makino T. Anti-allergic constituents in the culture medium of Ganoderma lucidum (II):The inhibitory effect of cyclooctasulfur on histamine release. Agents Actions.1988;23:157-60.
110. Morigiwa A, Kitabatake K, Fujimoto Y, Ihekawa N. Angiotensin converting enzyme inhibitory triterpenes from Ganoderma lucidum. Chem Pharm Bull. 1986;34:3025-8. (Pubitemid 16001863)
111. Lin ZB. Focus on anti-oxidative and free radical scavening activity of Ganoderma lucidum. J Appl Pharmacol. 2004;12:133-7.
112. Zhang Y, Mills G, Nair MG. Cyclooxygenase inhibitory and antioxidant compounds from the mycelia of the edible mushroom Grifola frondosa. J Agric Food Chem 2002;50:7581-5. (Pubitemid 35453719)
113. Faccin LC, Benati F, Rincão VP, Mantovani MS. Antiviral activity of aqueous and ethanol extracts and of an isolated polysaccharide from Agaricus brasiliensis against poliovirus type 1, Lett Appl Microbiol. 2007;45:24-8.
114. Collins RA, Ng TB. Polysaccharopeptide from Coriolus versicolor has potential for use against human immunodeficiency virus type 1 infection, Life Sci. 1997;60:383-7.
115. Akihisa T, Franzblau SG, Tokuda H, Tagata M. Antitubercular activity and inhibitory effect on Epstein-Barr virus activation of sterols and polyisoprenepolyols from an edible mushroom, Hypsizigus marmoreus. Biol Pharm Bull.2005;28:1117-9. (Pubitemid 40880329)
116. Mori K, Inatomi S, Ouchi K, Azumi Y, Tuchida T. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: A double-blind placebo-controlled clinical trial. Phytother Res 2009;23:367-72.
117. Wangun HV, Berg A, Hertel W, Nkengfack AE, Hertweck C. Anti-inflammatory and anti-hyaluronate lyase activities of lanostanoids from Piptoporus betulinus. J Antibiot (Tokyo) 2004;57:755-8. (Pubitemid 39602065)